MedTrace Logo

Detoxification and Treatment of Subjects With Medication Overuse Headache

NCT00432549 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2007-02-08

No results posted yet for this study

Summary

The purpose of this study is to assess the benefits of almotriptan used as a transitional therapy and topiramate in subjects with medication overuse headaches (MOH.

Conditions

  • Analgesic Rebound Headache

Interventions

DRUG

Almotriptan

DRUG

Topiramate

Sponsors & Collaborators

  • Ortho-McNeil Neurologics, Inc.

    collaborator INDUSTRY

  • The New England Center for Headache, P.C.

    lead OTHER

Principal Investigators

  • Fred D Sheftell, M.D. · The New England Center for Headache, P.C.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2007-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00432549 on ClinicalTrials.gov